{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:50:53Z","timestamp":1791280253069,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.eururo.2009.01.040","type":"journal-article","created":{"date-parts":[[2009,1,29]],"date-time":"2009-01-29T09:16:17Z","timestamp":1233220577000},"page":"1386-1396","source":"Crossref","is-referenced-by-count":106,"title":["Bladder Tumor Infiltrating Mature Dendritic Cells and Macrophages as Predictors of Response to Bacillus Calmette-Gu\u00e9rin Immunotherapy"],"prefix":"10.1016","volume":"55","author":[{"given":"Cherifa","family":"Ayari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"LaRue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Hovington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Decobert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Harel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Bergeron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"T\u00eatu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Lacombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Fradet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2009.01.040_bib1","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1067\/mcn.2001.117539","article-title":"Diagnosis and management of superficial bladder cancer","volume":"25","author":"Amling","year":"2001","journal-title":"Curr Probl Cancer"},{"key":"10.1016\/j.eururo.2009.01.040_bib2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.eururo.2007.08.015","article-title":"Intravesical pharmacotherapy for non\u2013muscle-invasive bladder cancer: a critical analysis of currently available drugs, treatment schedules, and long-term results","volume":"53","author":"Witjes","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2009.01.040_bib3","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.eururo.2008.04.051","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder","volume":"54","author":"Babjuk","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2009.01.040_bib4","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.biopha.2007.05.004","article-title":"Thirty years of BCG immunotherapy for non-muscle invasive bladder cancer: a success story with room for improvement","volume":"61","author":"Brandau","year":"2007","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.eururo.2009.01.040_bib5","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0022-5347(05)67707-5","article-title":"Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study","volume":"163","author":"Lamm","year":"2000","journal-title":"J Urol"},{"issue":"Suppl 3","key":"10.1016\/j.eururo.2009.01.040_bib6","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1086\/314064","article-title":"Efficacy and safety of bacille Calmette-Guerin immunotherapy in superficial bladder cancer","volume":"31","author":"Lamm","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eururo.2009.01.040_bib7","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.eururo.2007.10.006","article-title":"Prognostic factors in patients with non\u2013muscle-invasive bladder cancer treated with bacillus Calmette-Gu\u00e9rin: multivariate analysis of data from four randomized CUETO trials","volume":"53","author":"Fernandez-Gomez","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2009.01.040_bib8","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0302-2838(03)00048-4","article-title":"Do prognostic parameters of remission versus relapse after bacillus Calmette-Gu\u00e9rin (BCG) immunotherapy exist? Analysis of a quarter century of literature","volume":"43","author":"Saint","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2009.01.040_bib9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF00294021","article-title":"Leukocytes in the urine after intravesical BCG treatment for superficial bladder cancer. A flow cytofluorometric analysis","volume":"19","author":"de Boer","year":"1991","journal-title":"Urol Res"},{"key":"10.1016\/j.eururo.2009.01.040_bib10","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.vetimm.2004.04.007","article-title":"Interaction of antigen presenting cells with mycobacteria","volume":"100","author":"Hope","year":"2004","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.eururo.2009.01.040_bib11","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s10555-007-9072-0","article-title":"Inflammatory cell infiltration of tumors: Jekyll or Hyde","volume":"26","author":"Talmadge","year":"2007","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.eururo.2009.01.040_bib12","first-page":"4079","article-title":"Tumor-associated macrophage (TAM) infiltration in gastric cancer","volume":"23","author":"Ishigami","year":"2003","journal-title":"Anticancer Res"},{"key":"10.1016\/j.eururo.2009.01.040_bib13","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/ijc.10915","article-title":"Prognostic value of tumor-infiltrating dendritic cells expressing CD83 in human breast carcinomas","volume":"104","author":"Iwamoto","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.eururo.2009.01.040_bib14","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1111\/j.1572-0241.2004.30733.x","article-title":"Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus","volume":"99","author":"Koide","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.eururo.2009.01.040_bib15","first-page":"445","article-title":"Tumor associated macrophages in human prostate cancer: relation to clinicopathological variables and survival","volume":"17","author":"Lissbrant","year":"2000","journal-title":"Int J Oncol"},{"key":"10.1016\/j.eururo.2009.01.040_bib16","first-page":"5857","article-title":"Reduced infiltration of tumor-associated macrophages in human prostate cancer: association with cancer progression","volume":"60","author":"Shimura","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.eururo.2009.01.040_bib17","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1046\/j.1442-2042.2000.00190.x","article-title":"Prognostic value of tumor-associated macrophage count in human bladder cancer","volume":"7","author":"Hanada","year":"2000","journal-title":"Int J Urol"},{"key":"10.1016\/j.eururo.2009.01.040_bib18","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/cncr.23627","article-title":"Maintenance BCG in high-risk nonmuscle invasive bladder cancer: How much is enough?","volume":"113","author":"Decobert","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2009.01.040_bib19","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1023\/A:1006193704132","article-title":"Methodological challenges in the evaluation of prognostic factors in breast cancer","volume":"52","author":"Altman","year":"1998","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.eururo.2009.01.040_bib20","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/ijc.11352","article-title":"Urinary IL-2 assay for monitoring intravesical bacillus Calmette-Guerin response of superficial bladder cancer during induction course and maintenance therapy","volume":"107","author":"Saint","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.eururo.2009.01.040_bib21","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1365-2567.2007.02575.x","article-title":"BCG stimulated dendritic cells induce an interleukin-10 producing T-cell population with no T helper 1 or T helper 2 bias in vitro","volume":"121","author":"Madura","year":"2007","journal-title":"Immunology"},{"key":"10.1016\/j.eururo.2009.01.040_bib22","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1200\/JCO.2005.12.172","article-title":"Tumor-associated macrophages: the double-edged sword in cancer progression","volume":"23","author":"Chen","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2009.01.040_bib23","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/path.1027","article-title":"The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies","volume":"196","author":"Bingle","year":"2002","journal-title":"J Pathol"},{"key":"10.1016\/j.eururo.2009.01.040_bib24","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1182\/blood-2004-03-1109","article-title":"Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues","volume":"104","author":"Murdoch","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.eururo.2009.01.040_bib25","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/S0022-5347(05)00973-0","article-title":"The impact of age on the response of patients with superficial bladder cancer to intravesical immunotherapy","volume":"175","author":"Joudi","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2009.01.040_bib26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.exger.2007.06.008","article-title":"The immune system in extreme longevity","volume":"43","author":"Sansoni","year":"2008","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.eururo.2009.01.040_bib27","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1182\/blood.V81.6.1607.1607","article-title":"Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins","volume":"81","author":"Holness","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.eururo.2009.01.040_bib28","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s00240-003-0302-9","article-title":"Nitric oxide synthase expression in human bladder cancer and its relation to angiogenesis","volume":"31","author":"Lin","year":"2003","journal-title":"Urol Res"},{"key":"10.1016\/j.eururo.2009.01.040_bib29","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/sj.bjc.6602026","article-title":"Role of urothelial cells in BCG immunotherapy for superficial bladder cancer","volume":"91","author":"Bevers","year":"2004","journal-title":"Br J Cancer"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283809000529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283809000529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T04:33:33Z","timestamp":1589517213000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283809000529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0302283809000529"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2009.01.040","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}